Interferon alpha and omega antibody antagonists
US10759854B2 · kind B2 · utility
1Cited by
28References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 29, 2019 |
| Grant date | Sep 1, 2020 |
| Priority date | — |
| Expiry date | May 29, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies that broady neutralize interferon-α and interferon-ω, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.